TDOC Stock Recent News
TDOC LATEST HEADLINES
With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.
CHICAGO, March 12, 2025 (GLOBE NEWSWIRE) -- Cylinder , the leading virtual digestive health provider, today announced its partnership with Teladoc Health (NYSE: TDOC), the global leader in virtual care, to expand access to high-quality, personalized gastrointestinal care. Through this collaboration, Teladoc Health's health plan and employer customers can easily provide members access to Cylinder's evidence-based digestive health platform, through streamlined administrative services and integration enablement.
Teladoc (TDOC) closed at $9 in the latest trading session, marking a +0.78% move from the prior day.
NEW YORK , March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral on the company's Prism care platform New digital health partners in specialty care, digestive health, fertility, and family building available for Teladoc Health care team referral on the company's Prism care platform
TDOC expands weight care access with LillyDirect, boosting growth by offering affordable GLP-1 medications like Zepbound, enhancing patient outcomes and engagement.
NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE:TDOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Telemedicine operator Teladoc Health Inc TDOC has entered a pharmacy integration agreement with Eli Lilly And Co's LLY LillyDirect, a direct-to-consumer pharmacy partner, to streamline access to Zepbound (tirzepatide) for members of Teladoc's Comprehensive Weight Care Program.
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer website LillyDirect pharmacy partner, Gifthealth, to offer patients the weight-loss drug, Zepbound.